Literature DB >> 11242792

Pathologic features of breast cancers in women with previous benign breast disease.

T W Jacobs1, C Byrne, G Colditz, J L Connolly, S J Schnitt.   

Abstract

To compare pathologic features of the cancers arising after different types of benign breast disease (BBD), we reviewed the invasive breast cancer slides of 169 women with a previous benign biopsy result. Lesions were categorized previously as nonproliferative, proliferative without atypia, or atypical hyperplasia. Pathologic features of the cancers were evaluated without knowledge of the previous BBD category. Estrogen and progesterone receptor immunohistochemistry was performed on available tissue blocks. The median times between a benign result and cancer were 100, 124, and 92 months for women with nonproliferative lesions, proliferative lesions without atypia, and atypical hyperplasia, respectively. Cancers in the 3 groups did not differ significantly in tumor size, axillary lymph node status, or histologic grade, and there was no significant difference in the distribution of histologic types of breast cancer. Lymphatic vessel invasion, extensive intraductal component, and hormone receptor status did not differ among BBD categories. The pathologic features of breast cancers that develop in women with a previous benign biopsy result do not vary according to the histologic category of the previous BBD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242792     DOI: 10.1309/UP07-K3KD-25NL-D3M8

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.

Authors:  Daniel W Visscher; Marlene H Frost; Lynn C Hartmann; Ryan D Frank; Robert A Vierkant; Ann E McCullough; Stacey J Winham; Celine M Vachon; Karthik Ghosh; Kathleen R Brandt; Ann M Farrell; Yaman Tarabishy; Tina J Hieken; Tufia C Haddad; Ruth A Kraft; Derek C Radisky; Amy C Degnim
Journal:  Cancer       Date:  2015-10-29       Impact factor: 6.860

3.  Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.

Authors:  Lynn C Hartmann; Derek C Radisky; Marlene H Frost; Richard J Santen; Robert A Vierkant; Lorelle L Benetti; Yaman Tarabishy; Karthik Ghosh; Daniel W Visscher; Amy C Degnim
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-30

4.  Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.

Authors:  Jingfang Cheng; Shijing Qiu; Usha Raju; Sandra R Wolman; Maria J Worsham
Journal:  Breast Cancer Res Treat       Date:  2007-10-05       Impact factor: 4.872

5.  Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Authors:  Susanna D Mitro; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay; Baraa Alosh; Bassam Albashiti; Derek C Radisky; Marlene H Frost; Amy C Degnim; Julie J Ruterbusch; Michele L Cote
Journal:  Breast J       Date:  2014-09-08       Impact factor: 2.431

6.  Associations of reproductive breast cancer risk factors with breast tissue composition.

Authors:  Lusine Yaghjyan; Rebecca J Austin-Datta; Hannah Oh; Yujing J Heng; Adithya D Vellal; Korsuk Sirinukunwattana; Gabrielle M Baker; Laura C Collins; Divya Murthy; Bernard Rosner; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2021-07-05       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.